Palmitic acid reduces the autophagic flux in hypothalamic neurons by impairing autophagosome-lysosome fusion and endolysosomal dynamics

Mol Cell Oncol. 2020 Jul 25;7(5):1789418. doi: 10.1080/23723556.2020.1789418. eCollection 2020.

Abstract

High-fat diet (HFD)-induced obesity is associated with increased cancer risk. Long-term feeding with HFD increases the concentration of the saturated fatty acid palmitic acid (PA) in the hypothalamus. We previously showed that, in hypothalamic neuronal cells, exposure to PA inhibits the autophagic flux, which is the whole autophagic process from the synthesis of the autophagosomes, up to their lysosomal fusion and degradation. However, the mechanism by which PA impairs autophagy in hypothalamic neurons remains unknown. Here, we show that PA-mediated reduction of the autophagic flux is not caused by lysosomal dysfunction, as PA treatment does not impair lysosomal pH or the activity of cathepsin B.Instead, PA dysregulates autophagy by reducing autophagosome-lysosome fusion, which correlates with the swelling of endolysosomal compartments that show areduction in their dynamics. Finally, because lysosomes undergo constant dynamic regulation by the small Rab7 GTPase, we investigated the effect of PA treatment on its activity. Interestingly, we found PA treatment altered the activity of Rab7. Altogether, these results unveil the cellular process by which PA exposure impairs the autophagic flux. As impaired autophagy in hypothalamic neurons promotes obesity, and balanced autophagy is required to inhibit malignant transformation, this could affect tumor initiation, progression, and/or response to therapy of obesity-related cancers.

Keywords: Palmitic acid; Rab7; autophagy; central nervous system; electron microscopy; high-fat diet; hypothalamic neuronal cells; lysosomes; obesity-associated cancers.

Grants and funding

This work was founded by: grants from Fondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT 1160820 to E.M., 1171649 to P.V.B, 1171075 to AC, 3180209 to Y.Á., 11170546 to CTR; by the CONICYT PAI 77170091 to CTR by the ANID/PIA/ACT172066 to E.M., P.V.B, and A.C.; by ANID/PIA/ACT192015 to C.B.; by CONICYT PhD fellowships 21151609 to M.P.H-C, by the CONICYT Basal Programme No. AFB-170005 to P.V.B.; by CONICYT PCI REDI170147 to Y.Á., by the International Centre for Genetic Engineering and Biotechnology, ICGEB (CRP/CHL16-06 to E.M.).